• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Reckitt Benckiser (OP: RBGPF )

    57.50 +0.60 (+1.06%)
    Streaming Delayed Price Updated: 9:41 AM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 531
    Open 57.50
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 56.90
    Today's Range 57.50 - 57.50
    52wk Range 50.76 - 75.72
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
    Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt... 
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    What's Going On With Abbott Laboratories Stock On Friday?
    An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about... 
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal

    Performance

    YTD
    -16.65%
    -16.65%
    1 Month
    -2.31%
    -2.31%
    3 Month
    +3.92%
    +3.92%
    6 Month
    -22.76%
    -22.76%
    1 Year
    -21.81%
    -21.81%

    More News

    Read More
    Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
    Via Benzinga
    FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
    Via Benzinga
    Exposures Product Safety
    British Consumer Company Reckitt Benckiser's CEO Steps Down
    Via Benzinga
    Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
    Via Benzinga
    Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
    Via Benzinga
    Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
    Via Benzinga
    Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
    Via MarketBeat
    Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage
    Via Benzinga
    More Companies Join Race To Ease US Baby Formula Supply Crunch
    Via Benzinga
    Danone Scales Up Baby Formula Shipments To US To Combat Shortage: Reuters
    Via Benzinga
    Morning Brief: Top Financial Stories Dominating on Friday, April 29
    Via Benzinga
    Reckitt Benckiser Hikes Prices To Compensate For Falling Demand: FT
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.